193 related articles for article (PubMed ID: 31406553)
41. The gut microbiota of Colombians differs from that of Americans, Europeans and Asians.
Escobar JS; Klotz B; Valdes BE; Agudelo GM
BMC Microbiol; 2014 Dec; 14():311. PubMed ID: 25495462
[TBL] [Abstract][Full Text] [Related]
42. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
43. Cross-Regional View of Functional and Taxonomic Microbiota Composition in Obesity and Post-obesity Treatment Shows Country Specific Microbial Contribution.
Medina DA; Li T; Thomson P; Artacho A; Pérez-Brocal V; Moya A
Front Microbiol; 2019; 10():2346. PubMed ID: 31681211
[TBL] [Abstract][Full Text] [Related]
44. Alterations to the microbiota-colon-brain axis in high-fat-diet-induced obese mice compared to diet-resistant mice.
Zhang P; Yu Y; Qin Y; Zhou Y; Tang R; Wang Q; Li X; Wang H; Weston-Green K; Huang XF; Zheng K
J Nutr Biochem; 2019 Mar; 65():54-65. PubMed ID: 30623851
[TBL] [Abstract][Full Text] [Related]
45. Stronger anti-obesity effect of white ginseng over red ginseng and the potential mechanisms involving chemically structural/compositional specificity to gut microbiota.
Zhou SS; Auyeung KK; Yip KM; Ye R; Zhao ZZ; Mao Q; Xu J; Chen HB; Li SL
Phytomedicine; 2020 Aug; 74():152761. PubMed ID: 31005370
[TBL] [Abstract][Full Text] [Related]
46. Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis
Liu MT; Huang YJ; Zhang TY; Tan LB; Lu XF; Qin J
World J Gastroenterol; 2019 Jul; 25(27):3590-3606. PubMed ID: 31367159
[TBL] [Abstract][Full Text] [Related]
47. Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent.
Hamilton MK; Boudry G; Lemay DG; Raybould HE
Am J Physiol Gastrointest Liver Physiol; 2015 May; 308(10):G840-51. PubMed ID: 25747351
[TBL] [Abstract][Full Text] [Related]
48. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: a randomized double-blind controlled clinical trial.
Lee SJ; Bose S; Seo JG; Chung WS; Lim CY; Kim H
Clin Nutr; 2014 Dec; 33(6):973-81. PubMed ID: 24411490
[TBL] [Abstract][Full Text] [Related]
49. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
50. Gut bacterial microbiota and obesity.
Million M; Lagier JC; Yahav D; Paul M
Clin Microbiol Infect; 2013 Apr; 19(4):305-13. PubMed ID: 23452229
[TBL] [Abstract][Full Text] [Related]
51. Programming of host metabolism by the gut microbiota.
Bäckhed F
Ann Nutr Metab; 2011; 58 Suppl 2():44-52. PubMed ID: 21846980
[TBL] [Abstract][Full Text] [Related]
52. Characterization of the Gut Microbial Community of Obese Patients Following a Weight-Loss Intervention Using Whole Metagenome Shotgun Sequencing.
Louis S; Tappu RM; Damms-Machado A; Huson DH; Bischoff SC
PLoS One; 2016; 11(2):e0149564. PubMed ID: 26919743
[TBL] [Abstract][Full Text] [Related]
53. The microbiota-gut-brain axis in obesity.
Torres-Fuentes C; Schellekens H; Dinan TG; Cryan JF
Lancet Gastroenterol Hepatol; 2017 Oct; 2(10):747-756. PubMed ID: 28844808
[TBL] [Abstract][Full Text] [Related]
54. The Gut Bacteria-Driven Obesity Development.
Compare D; Rocco A; Sanduzzi Zamparelli M; Nardone G
Dig Dis; 2016; 34(3):221-9. PubMed ID: 27028448
[TBL] [Abstract][Full Text] [Related]
55. Gut Microbiota: From Microorganisms to Metabolic Organ Influencing Obesity.
Stephens RW; Arhire L; Covasa M
Obesity (Silver Spring); 2018 May; 26(5):801-809. PubMed ID: 29687647
[TBL] [Abstract][Full Text] [Related]
56. A high linoleic acid diet exacerbates metabolic responses and gut microbiota dysbiosis in obese rats with diabetes mellitus.
Lee HC; Yu SC; Lo YC; Lin IH; Tung TH; Huang SY
Food Funct; 2019 Feb; 10(2):786-798. PubMed ID: 30672576
[TBL] [Abstract][Full Text] [Related]
57. Association of gut microbiota with obesity in children and adolescents.
Cho KY
Clin Exp Pediatr; 2023 Apr; 66(4):148-154. PubMed ID: 36397257
[TBL] [Abstract][Full Text] [Related]
58. Maraviroc modifies gut microbiota composition in a mouse model of obesity: a plausible therapeutic option to prevent metabolic disorders in HIV-infected patients.
Pérez-Matute P; Pérez-Martínez L; Aguilera-Lizarraga J; Blanco JR; Oteo JA
Rev Esp Quimioter; 2015 Aug; 28(4):200-6. PubMed ID: 26200028
[TBL] [Abstract][Full Text] [Related]
59. Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity.
Qiao Y; Sun J; Xia S; Tang X; Shi Y; Le G
Food Funct; 2014 Jun; 5(6):1241-9. PubMed ID: 24722352
[TBL] [Abstract][Full Text] [Related]
60. Intestinal Sensing by Gut Microbiota: Targeting Gut Peptides.
Covasa M; Stephens RW; Toderean R; Cobuz C
Front Endocrinol (Lausanne); 2019; 10():82. PubMed ID: 30837951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
